Repligen Corporation (RGEN) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $133.65
• Market Cap: $7.44B
• P/E Ratio: 153.65
• EPS: $0.86
• 52-Week High: $175.77
• 52-Week Low: $102.97

Market Sentiment

Repligen Corporation currently has a Bullish sentiment score of 0.24.

About Repligen Corporation

Repligen Corporation, headquartered in Waltham, Massachusetts, is a leading provider of bioprocessing technologies and systems that enhance the development and manufacturing of biologic drugs. The company's innovative solutions, which span from upstream to downstream processes, are utilized by biopharmaceutical companies worldwide, including in North America, Europe, and Asia Pacific. With a focus on high-quality products and ongoing innovation, Repligen is well-positioned to capitalize on th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Repligen Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RGEN pay dividends?

Repligen Corporation (RGEN) does not currently pay a regular dividend.

What is RGEN's P/E ratio?

Repligen Corporation has a price-to-earnings (P/E) ratio of 153.65.

What is RGEN's market cap?

Repligen Corporation (RGEN) has a market capitalization of $7.44B with a current stock price of $133.65.